The Effect of Helicobactger pylori Eradication in Patients with Reflux Esophagitis by Symptom Analysis and Endoscopic Assessment

역류성 식도염 환자에서 Helicobacter pylori 치료 1년 후 증상과 내시경적 변화

Lim, Yun-Jeong;Rhee, Poong-Lyul;Kim, Young-Ho;Park, Dong-Il;Lee, Jun-Haeng;Son, Hee-Jung;Kim, Jae-J.;Koh, Kwang-Cheol;Paik, Seung-Woon;Rhee, Jong-Chul;Choi, Kyoo-Wan
임윤정;이풍렬;김영호;박동일;이준행;손희정;김재준;고광철;백승운;이종철;최규완

  • Published : 20020000

Abstract

Background/Aims: The relationship between Helicobacter pylori (H. pylori) infection and gastroesophageal reflux disease (GERD) is controversial. A high incidence of reflux esophagitis after H. pylori eradication has been reported in patients with peptic ulcer. However, few study has been reported on the effects of H. pylori eradication in patients with GERD without peptic ulcer. We assessed the reflux symptoms and endoscopic findings among comparable patients having undergone successful versus failed H. pylori eradication. Methods: Patients with H. pylori-positive endoscopic esophagitis were treated with omeprazole, amoxicillin and metronidazole for 2 weeks and subsequently underwent 8-weeks of omeprazole treatment. All patients underwent a urea breath test 2-4 weeks later. Patients underwent symptom assessment and endoscopy before the therapy and 1 year thereafter. Results: Out of 48 patients randomized, 10 dropped out during the follow-up period, leaving 38 patients with analyzable results. H. pylori eradication was successful in 32 patients (84.2%). By the end of the follow-up period, patients with symptoms (p=0.107) or endoscopic esophagitis (p=0.366) seemed not to be more aggravated in the successful than in the failed eradication group. Conclusions: H. pylori eradication doesn't aggravate the symptoms or endoscopic esophagitis in patients with H. pylori-positive reflux esophagitis.

Keywords

References

  1. Varanasi RV, Fantry GT, Wilson KT. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter 1998;3:188-194 https://doi.org/10.1046/j.1523-5378.1998.08001.x
  2. Vakil N, Hahn B, McSorley D. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:45-51 https://doi.org/10.1046/j.1365-2036.2000.00677.x
  3. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327-333 https://doi.org/10.1136/gut.43.3.327
  4. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-1447 https://doi.org/10.1016/S0016-5085(97)70024-6
  5. Fallone CA, Barkun AN, Friedman G, et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 2000;95:914-920
  6. McColl KE, Dickson A, EI-Nujumi A, El-Omar E, Kelman A. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease. Am J Gastroenterol 2000;95:101-105
  7. Wu JC, Sung JJ, Ng EK, et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol 1999;94: 1790-1794 https://doi.org/10.1111/j.1572-0241.1999.01207.x
  8. Labenz J, Malfertheiner P. Helicobacter pylori in gastrooesophageal reflux disease: causal agent, independent or protective factor? Gut 1997;41:277-280
  9. Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997;42: 103-105 https://doi.org/10.1023/A:1018841222856
  10. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication N Engl J Med 1996;334:1018-1022
  11. Ollyo JB, Lang F, Fontolliet C, et al. Savary-Miller's new endoscopic grading of reflux-oesophagitis: a simple, reprodicible, logical, complete and useful classification. Gastroenterology 1990;98: 100A
  12. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998;7:75-83 https://doi.org/10.1023/A:1008841022998
  13. 진윤태, 전훈재, 이성준 등. Helicobacter pylori 감염 진단을 위한 $^{13}C$ 요소호기검사의 유용성 평가, 다기관 공개 비교 임상시험. 대한내과학회지 1999;56:677-684
  14. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 1999;94:3468-3472 https://doi.org/10.1111/j.1572-0241.1999.01593.x
  15. Holtmann G, Cain C, Malfertheiner P. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999;117:11-16 https://doi.org/10.1016/S0016-5085(99)70544-5
  16. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol 1999;94:884-887 https://doi.org/10.1111/j.1572-0241.1999.982_e.x
  17. Newton M, Bryan R, Burnham WR, Kamm MA. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 1997;40:9-13 https://doi.org/10.1136/gut.40.1.9
  18. Ouatu-Lascar R, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1998;93:711-716 https://doi.org/10.1111/j.1572-0241.1998.211_a.x
  19. Koop H, Arnold R. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with Hrblocker-resistant esophagitis. Dig Dis Sci 1991;36:552-557 https://doi.org/10.1007/BF01297018
  20. 김병욱, 최명규, 최황 등 국내에서 보고된 Helicobacter pylori 세균요법의 분석, 대한소화기학회지 1998;34:42-49
  21. 문광호, 함준수, 류광현 등. Helicobacter pylori 균주의 metronidazole내성이 균 박멸에 미치는 영향. 대한소화기내시경학회지 1998; 18:847-852
  22. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335:205-208 https://doi.org/10.1016/0140-6736(90)90287-F